The functional significance of vasomotor arteries dysfunction in the clinical assessment of myocardial ischemia in case of carbohydrate metabolism disorder
- 作者: Tatarchenko I.1, Pozdnyakova N.1,2, Mordovina A.1,2, Morozova O.1
-
隶属关系:
- Penza Extension Course Institute for Medical Practitioners
- Federal State Health Institution, Medical Unit−59, Penza
- 期: 卷 5, 编号 2 (2014)
- 页面: 31-35
- 栏目: Articles
- URL: https://journals.rcsi.science/2221-7185/article/view/45085
- DOI: https://doi.org/10.26442/CS45085
- ID: 45085
如何引用文章
全文:
详细
作者简介
I. Tatarchenko
Penza Extension Course Institute for Medical Practitionersд-р мед. наук, проф., зав. каф. терапии, кардиологии и функциональной диагности- ки
N. Pozdnyakova
Penza Extension Course Institute for Medical Practitioners; Federal State Health Institution, Medical Unit−59, Penza
Email: pozdnyakova-n-v@rambler.ru
д-р мед. наук, проф. каф. терапии, кардиологии и функциональной диагностики ГБОУ ДПО ПИУВ; гл. терапевт ФГБУЗ Медико-санитарная часть №5
A. Mordovina
Penza Extension Course Institute for Medical Practitioners; Federal State Health Institution, Medical Unit−59, Penzaканд. мед. наук, доц. каф. терапии, кардиологии и функциональной диагностики ГБОУ ДПО ПИУВ; врач-эндокринолог ФГБУЗ Медико-санитарная часть №59
O. Morozova
Penza Extension Course Institute for Medical Practitionersд-р мед. наук, проф. каф. терапии, кардиологии и функциональной диагностики
参考
- Zarich S.W, Nesto R.W. Diabetic cardiomyopathy. Am Heart J 1989; 118 (5): 1000-12.
- Killip T. Silent Myocardial Ischemia: Some good news. Circulation 1997; 95: 1992-3.
- Schoenenberger A.W, Jamshidi P, Kobza R et al. Progression of coronary artery disease during long - term follow - up of the Swiss Interventional Study on Silent Ischemia Type II (SWISSI II). Clin Cardiol 2010; 33 (5): 289-95.
- Jermendy G, Davidovits Z, Khoor S. Silent coronary artery disease in diabetic patients with cardiac autonomic neuropathy. Diabetes Care 1994; 17: 1231-2.
- Gokcel A, Aydin M, Yalcin F. Silent coronary artery disease in patients with type 2 diabetes mellitus. Acta Diabetol 2003; 40: 176-80.
- Dzau V, Bernstein K, Celermajer D et al. Pathophysiologic and therapeutic implications of tissue ACE: a consensus report. Cardiovasc Drugs Ther 2002; 16 (2): 149-60.
- Cipolla M. Diabetes and Endothelial Dysfunction: A Clinical Perspective. Endocr Rev 2001; 22 (1): 36-52.
- Vanhoutte P.M, Boulanger C.M. Endotheliumdependent responses in hypertension. Hypertens Res 1995; 18 (2): 87-98.
- Schachinger V, Britten M.B, Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long - term outcome of coronary heart disease. Circulation 2000; 101: 1899-906.
- Celermajer D.S, Sorensen K.E. Non - invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.